comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 21:39:58 - browse：4125

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Parents surprise family after baby discharged from NICU after 170 days

knowledge

WSS

Swim instructor mom warns parents not to buy blue swimsuits for kids

Pandemic and All Hazards Preparedness Act needs lean update

Create a giant ice tray with this foil pan hack to keep food cold this summer

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

Wisconsin governor employs partial veto to fund schools for 4 centuries

Judge agrees to delay next hearing in Trump classified documents case

entertainment

comprehensive

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Psychedelics group wrestles with new pharma identity

‘The Bear’ and hospitality in hospitals

Medical leaders decry Supreme Court decision on affirmative action

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

After affirmative action ruling, medical educators look to 'holistic review'

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Cancer drug shortages should be causing more outrage

Eisai exec who led development of Alzheimer’s drug to retire

entertainment

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

An Ebola outbreak presents a new mystery involving children

Former Georgia lieutenant governor says he received grand jury subpoena

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

The aspartame in Diet Coke probably isn’t giving you cancer

explore

knowledge

entertainment

hotspot